Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hana Kurz
Institutions:
Levine Cancer Institute,
Wake Forest University
Observed institutions:
Levine Cancer Institute,
Wake Forest University
ORCID:
0009-0000-1091-1244
Observed ORCID:
0009-0000-1091-1244
OpenAlex ID:
A5126884357
Outpatient bispecific step-up dosing with prophylactic dexamethasone: impact on resource utilization and estimated cost
2026
·
Christopher J. Ferreri
, Shebli Atrash
, et al.
·
Blood Immunology & Cellular Therapy
·
1
Omidubicel for Hematopoietic Cell Transplants: Considerations for Patients and Treatment Outcomes
2024
·
Allison Morse
, Hana Kurz
, et al.
·
Patient Preference and Adherence
·
1
PDF
Prophylactic tocilizumab for bispecific T-cell engagers in multiple myeloma: current evidence and clinical considerations for mitigating cytokine release syndrome
2026
·
Hana Kurz
, Jessica McElwee
, et al.
·
Expert Review of Hematology
Incidence of endocrine toxicities in patients with solid tumor malignancies receiving curative-intent immune checkpoint inhibitor (ICI) therapy: A single institution experience
2026
·
Hana Kurz
, Hang Zeng
, et al.
·
Journal of Oncology Pharmacy Practice
Show more works
View as search
Works count:
4
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type